Trial Search Results

Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma

Primary Objective:

To compare the efficacy of TACE vs. CyberKnife SBRT in the treatment of locally recurrent HCC after initial TACE.

Secondary Objectives:

1. To determine the progression-free survival of TACE vs. CyberKnife SBRT

2. To determine the overall survival of TACE vs. CyberKnife SBRT for locally recurrent HCC

3. To determine the toxicities associated with TACE or CyberKnife SBRT for the treatment of recurrent HCC.

Stanford is currently not accepting patients for this trial.

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Laurie Ann Columbo
6507360792
Not Recruiting